首页> 美国卫生研究院文献>other >Oleanolic Acid Suppresses Migration and Invasion of Malignant Glioma Cells by Inactivating MAPK/ERK Signaling Pathway
【2h】

Oleanolic Acid Suppresses Migration and Invasion of Malignant Glioma Cells by Inactivating MAPK/ERK Signaling Pathway

机译:齐墩果酸通过失活MAPK / ERK信号通路抑制恶性胶质瘤细胞的迁移和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mitogen-activated protein kinases/Extracellular signal-regulated kinase (MAPK/ERK) pathway is essential for migration and invasion of malignant glioma. It is efficient to inhibit migration and invasion of glioma cells by targeting this pathway. Oleanolic acid (OA) has been well demonstrated to suppress survival, growth and angiogenesis of glioma cells. However, it is still unknown if OA affects the migration and invasion of glioma cells. We utilized U-87 MG glioma cell lines and primary glioma cells from patients to study the effect of OA on migration and invasion of glioma cells with multidisciplinary approaches. In this study, we found that OA significantly decreased the ability of glioma cells to migrate and invade. Epithelial-mesenchymal transition (EMT) of glioma cells was also suppressed by OA treatment. Furthermore, MAPK/ERK pathway was greatly inhibited in glioma cells under OA treatment. MAPK/ERK reactivation induced by a recombinant lentiviral vector, Lv-MEK, was able to rescue the inhibitory effect of OA on migration and invasion of glioma cells. Taken together, we provided evidences that OA was a MAPK/ERK pathway-targeting anti-tumor agent. Although the concentrations we used exceeded its physiological level, OA may be used to prevent migration and invasion of glioma cells by developing its derivatives with enhanced bioactivity.
机译:丝裂原激活的蛋白激酶/细胞外信号调节激酶(MAPK / ERK)途径对于恶性神经胶质瘤的迁移和侵袭至关重要。通过靶向该途径可有效抑制神经胶质瘤细胞的迁移和侵袭。齐墩果酸(OA)已被证明可以抑制神经胶质瘤细胞的存活,生长和血管生成。但是,OA是否会影响神经胶质瘤细胞的迁移和侵袭尚不清楚。我们利用患者的U-87 MG神经胶质瘤细胞系和原发性神经胶质瘤细胞,通过多学科方法研究了OA对神经胶质瘤细胞迁移和侵袭的影响。在这项研究中,我们发现OA显着降低了胶质瘤细胞迁移和侵袭的能力。 OA治疗还抑制了神经胶质瘤细胞的上皮-间质转化(EMT)。此外,在OA处理下,神经胶质瘤细胞中的MAPK / ERK途径被大大抑制。重组慢病毒载体Lv-MEK诱导的MAPK / ERK激活能够挽救OA对神经胶质瘤细胞迁移和侵袭的抑制作用。综上所述,我们提供了证据表明OA是一种靶向MAPK / ERK途径的抗肿瘤药物。尽管我们使用的浓度超过了其生理水平,但OA可以通过开发具有增强生物活性的衍生物来防止神经胶质瘤细胞的迁移和侵袭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号